Medicare Enrolled
Dr. Carlo Hatem, MD
Pulmonary Disease · El Paso, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Hatem from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Hatem?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Hatem
Dr. Carlo Hatem is a pulmonary disease specialist in El Paso, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Hatem performed 2,106 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Hatem received a total of $10,236 from 39 pharmaceutical and/or device companies across 378 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Hatem is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years of NPI registration
▲ Top 18% volume in TX
$10,236 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗2,106
Medicare services
Top 18% in TX for pulmonary disease
Not available
Unique patients (not deduplicated)
$87
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
529 | $165 | $525 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
458 | $89 | $304 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
289 | $61 | $189 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
117 | $33 | $110 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
116 | $23 | $77 |
| Lung volume test using sensors A test that measures the amount of air in the lungs using sensors. |
112 | $32 | $106 |
| Ceftriaxone antibiotic injection This code represents the administration of ceftriaxone sodium, an antibiotic medication. The charge is calculated for every 250 mg of the drug administered. |
80 | $0 | $20 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
75 | $128 | $426 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
65 | $10 | $34 |
| Chest X-ray, 2 views An X-ray imaging test of the chest that captures two different angles to visualize the lungs, heart, and chest wall. |
63 | $25 | $80 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
50 | $126 | $395 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
33 | $58 | $215 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
33 | $99 | $311 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
23 | $91 | $285 |
| Methylprednisolone acetate injection, 80 mg An injection of 80 mg of methylprednisolone acetate, a corticosteroid medication. |
23 | $9 | $80 |
| CT scan of chest, without contrast A computed tomography scan of the chest area that uses X-rays to create detailed images without the use of contrast dye. |
15 | $90 | $328 |
| Sedation by physician, initial 15 minutes Administration of a drug to induce depression of consciousness by the physician performing a procedure. This code covers the initial 15 minutes of sedation for patients aged 5 years or older. |
14 | $10 | $119 |
| Bronchoscopy A diagnostic exam of the lung airways using an endoscope to visually inspect the inside of the lungs and airways. |
11 | $100 | $388 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$10,236
Total received (2018-2024)
Avg $1,462/year across 7 years
Top 20% in TX for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
39
Companies
378
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$4,025
2023
$1,375
2022
$1,343
2021
$594
2020
$540
2019
$1,248
2018
$1,112
Payments by company (2024)
INTUITIVE SURGICAL, INC.
$2,590
AstraZeneca Pharmaceuticals LP
$429
Regeneron Healthcare Solutions, Inc.
$302
Boehringer Ingelheim Pharmaceuticals, Inc.
$152
GlaxoSmithKline, LLC.
$136
Mylan Specialty L.P.
$109
GENZYME CORPORATION
$108
Novartis Pharmaceuticals Corporation
$88
Actelion Pharmaceuticals US, Inc.
$22
Philips North America LLC
$21
Amgen Inc.
$19
Merck Sharp & Dohme LLC
$17
Eurofins Viracor, LLC
$17
Insmed, Inc.
$14
Top 3 companies account for 82.5% of 2024 payments
All-time payments by company (2018-2024) ›
INTUITIVE SURGICAL, INC.
$2,590
AstraZeneca Pharmaceuticals LP
$1,883
GlaxoSmithKline, LLC.
$1,357
Boehringer Ingelheim Pharmaceuticals, Inc.
$615
Regeneron Healthcare Solutions, Inc.
$535
Mylan Specialty L.P.
$407
Pulmonx Corporation
$349
Sunovion Pharmaceuticals Inc.
$328
Novartis Pharmaceuticals Corporation
$301
Grifols USA, LLC
$236
Actelion Pharmaceuticals US, Inc.
$189
GENZYME CORPORATION
$188
Ethicon Inc.
$140
Sirtex Medical Inc
$130
Genentech USA, Inc.
$109
Penumbra, Inc.
$91
Gilead Sciences, Inc.
$85
Philips Electronics North America Corporation
$70
Amgen Inc.
$58
Insmed, Inc.
$57
United Therapeutics Corporation
$49
La Jolla Pharmaceutical Company
$49
Teva Pharmaceuticals USA, Inc.
$38
Biogen, Inc.
$37
Circassia Pharmaceuticals Inc
$37
ABBVIE INC.
$36
Baxter Healthcare
$33
Merck Sharp & Dohme LLC
$33
PFIZER INC.
$30
Inogen, Inc.
$29
Alexion Pharmaceuticals, Inc.
$23
Philips North America LLC
$21
Eurofins Viracor, LLC
$17
Advanced Respiratory, Inc
$16
BOSTON SCIENTIFIC CORPORATION
$16
Phadia US Inc.
$16
CHIESI USA, INC.
$15
EKOS Corporation
$12
Merck Sharp & Dohme Corporation
$12
Top 3 companies account for 57.0% of all-time payments
Associated products mentioned in payments ›
(AK6) Vest Therapy · AIRSUPRA · ANORO · ANORO ELLIPTA · AREXVY · AVAGE · AVYCAZ · AirDuo Digihaler · Arikayce · BREO · BREZTRI · BRILINTA · CHARTIS CATHETER · CLEVIPREX 25MG/50ML · DUAKLIR PRESSAIR · DUPIXENT · Da Vinci Surgical System · Dymista · EKOSONIC · ELIQUIS · EXALT · FASENRA · GIAPREZA · Hillrom - Life 2000 Ventilation System · Hillrom - Vest System Model 105 Home Care · INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH · ImmunoCAP · KEYTRUDA · LOKELMA · LONHALA MAGNAIR · Monarch Platform · NUCALA · OFEV · OPSUMIT · ORENITRAM · PREVNAR 20 · ProAir Digihaler · Prolastin-C Liquid · Pulmonx Endobronchial Valve EBV · RUBY Coil · Respiratoriy Care Undiv · SEEBRI · SIR-Spheres Microspheres · SPINRAZA · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SYMBICORT · Sleep Other · TAGRISSO · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · TYVASO · The Vest System Model 105 Home Care · ULTOMIRIS · UPTRAVI · Utibron · Veklury · XOLAIR · Xolair · YUPELRI · Yupelri · ZERBAXA
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Pulmonary diseases in nearby ZIP areas
13
County median income
$58,859
Nearest hospital to ZIP centroid (approximate)
THE HOSPITALS OF PROVIDENCE - MEMORIAL CAMPUS
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Hatem is a clinical cardiology specialist, with above-average Medicare volume (top 18% in TX), with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Hatem experienced with critical care, first 30-74 min?
Based on Medicare claims data, Dr. Hatem performed 529 critical care, first 30-74 min services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Hatem receive payments from pharmaceutical companies?
Yes. Dr. Hatem received a total of $10,236 from 39 companies across 378 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Hatem's costs compare to other pulmonary diseases in El Paso?
Dr. Hatem's average Medicare payment per service is $87. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Hatem) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in El Paso
Browse pulmonary diseases in El Paso ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in TX
Pulmonary diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in TX
Which TX pulmonary diseases receive the most from drug and device companies.
By company
INTUITIVE SURGICAL, INC. Payments to Doctors
See all physicians who received payments from INTUITIVE SURGICAL, INC.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology